Compare GoPro Inc (GPRO) vs Organon & Co. Common Stock (OGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GoPro Inc vs Organon & Co. Common Stock — how do they compare? GoPro Inc trades at $1.11 (market cap $238.34M), while Organon & Co. Common Stock trades at $13.73 (market cap $3.61B). The key difference: Organon & Co. Common Stock is far larger — about 15.1× GoPro Inc's market cap, and Organon & Co. Common Stock pays a 0.58% dividend while GoPro Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold GoPro Inc for 45 Days and Organon & Co. Common Stock for 0 Days on average.
| GPRO | OGN | |
|---|---|---|
Market Cap | $238.34M | $3.61B |
Volume | 5,242,039 | 1,808,049 |
Sector | Technology | Health |
52-Week High | $2.31 | $13.81 |
52-Week Low | $0.58 | $5.70 |
Typical Hold Time | 45 Days | 0 Days |
Enterprise Value | $297.12M | $11.03B |
Dividend Yield | — | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GoPro (GPRO) trades at $1.18, down 0.84% on the day, following recent volatility driven by merger speculation and influencer investment. The stock shows bullish technical signals with oversold RSI conditions, while fundamentals reveal persistent challenges with negative net income margins (-28.52%) and declining revenue trends from $1.1B in 2022 to $652M in 2025. The company announced a $285 million merger with Starman Optical and received 11 industry awards for its MISSION 1 series, providing potential catalysts amid ongoing financial struggles.
Investment outlook remains highly speculative with significant execution risks. The merger offers potential upside but faces shareholder litigation over valuation concerns. Analyst consensus shows cautious sentiment with only 21% buy ratings, while cash flow deficits and competitive pressures from smartphone technology create substantial headwinds for sustainable recovery.
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About GoPro Inc
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
Read more on GPRO →About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →
